Charles Schwab
NGVT icon

Charles Schwab’s Ingevity NGVT Stock Holding History

Charles Schwab’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4M Sell
541,400
-66,852
-11% -$4.81M 0.01% 1393
2026
Q1 		$43.3M Sell
608,252
-58,700
-9% -$4.01M 0.01% 1255
2025
Q4 		$39.5M Sell
666,952
-17,818
-3% -$967K 0.01% 1302
2025
Q3 		$37.8M Sell
684,770
-34,274
-5% -$1.78M 0.01% 1330
2025
Q2 		$31M Buy
719,044
+17,289
+2% +$667K 0.01% 1416
2025
Q1 		$27.8M Buy
701,755
+55,488
+9% +$2.46M 0.01% 1439
2024
Q4 		$26.3M Buy
646,267
+38,639
+6% +$1.61M ﹤0.01% 1545
2024
Q3 		$23.7M Buy
607,628
+50,692
+9% +$2.02M ﹤0.01% 1605
2024
Q2 		$24.3M Buy
556,936
+15,245
+3% +$737K ﹤0.01% 1547
2024
Q1 		$25.8M Buy
541,691
+57,715
+12% +$2.59M 0.01% 1463
2023
Q4 		$22.9M Buy
483,976
+44,910
+10% +$1.87M 0.01% 1511
2023
Q3 		$20.9M Buy
439,066
+25,550
+6% +$1.39M 0.01% 1483
2023
Q2 		$24.1M Buy
413,516
+14,965
+4% +$898K 0.01% 1362
2023
Q1 		$28.5M Sell
398,551
-690
-0.2% -$54.8K 0.01% 1207
2022
Q4 		$28.1M Buy
399,241
+4,596
+1% +$324K 0.01% 1190
2022
Q3 		$23.9M Sell
394,645
-501
-0.1% -$33.6K 0.01% 1249
2022
Q2 		$24.9M Buy
395,146
+8,965
+2% +$584K 0.01% 1229
2022
Q1 		$24.7M Buy
386,181
+11,924
+3% +$798K 0.01% 1370
2021
Q4 		$26.8M Buy
374,257
+9,214
+3% +$701K 0.01% 1354
2021
Q3 		$26.1M Sell
365,043
-5,526
-1% -$436K 0.01% 1354
2021
Q2 		$30.1M Sell
370,569
-1,296
-0.3% -$104K 0.01% 1245
2021
Q1 		$28.1M Buy
371,865
+35,268
+10% +$2.57M 0.01% 1236
2020
Q4 		$25.5M Buy
336,597
+6,642
+2% +$433K 0.01% 1220
2020
Q3 		$16.3M Sell
329,955
-2,699
-0.8% -$152K 0.01% 1344
2020
Q2 		$17.5M Buy
332,654
+5,279
+2% +$251K 0.01% 1274
2020
Q1 		$11.5M Buy
327,375
+10,314
+3% +$602K 0.01% 1372
2019
Q4 		$27.7M Buy
317,061
+3,293
+1% +$288K 0.01% 987
2019
Q3 		$26.6M Sell
313,768
-10,530
-3% -$938K 0.02% 963
2019
Q2 		$34.1M Sell
324,298
-15,020
-4% -$1.51M 0.02% 790
2019
Q1 		$35.8M Buy
339,318
+58,250
+21% +$5.85M 0.02% 738
2018
Q4 		$23.5M Sell
281,068
-2,921
-1% -$264K 0.02% 888
2018
Q3 		$28.9M Buy
283,989
+9,701
+4% +$936K 0.02% 891
2018
Q2 		$22.2M Buy
274,288
+4,288
+2% +$341K 0.02% 1002
2018
Q1 		$19.9M Buy
270,000
+9,443
+4% +$706K 0.02% 1008
2017
Q4 		$18.4M Buy
260,557
+26,655
+11% +$1.92M 0.01% 1046
2017
Q3 		$14.6M Buy
233,902
+43,508
+23% +$2.58M 0.01% 1149
2017
Q2 		$10.9M Buy
190,394
+16,078
+9% +$946K 0.01% 1287
2017
Q1 		$10.6M Buy
174,316
+12,010
+7% +$679K 0.01% 1280
2016
Q4 		$8.9M Buy
162,306
+5,368
+3% +$257K 0.01% 1342
2016
Q3 		$7.24M Buy
156,938
+13,588
+9% +$574K 0.01% 1395
2016
Q2 		$4.88M Buy
+143,350
New +$4.48M 0.01% 1570

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Charles Schwab's NGVT Position: Q2 2026 in Review

Charles Schwab reduced its Ingevity (NGVT) stake by 11% in Q2 2026, selling an estimated $4.81M and leaving 541,400 shares worth $40.4M. The position accounts for 0.01% of the portfolio, ranked #1393.

Charles Schwab first reported a position in NGVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $43.3M in Q1 2026. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Charles Schwab held 541,400 shares of Ingevity worth $40.4M as of Q2 2026.
  • Charles Schwab sold 66,852 Ingevity shares in Q2 2026, an estimated $4.81M.
  • Ingevity made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1393 holding.
  • Charles Schwab first reported a position in Ingevity in Q2 2016 and has held it in 41 quarters since.
  • Charles Schwab's Ingevity position peaked at $43.3M in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.